Marrone Bio Innovations, Inc.
MBII
MBII was delisted on the 12th of July, 2022.
62 hedge funds and large institutions have $69.8M invested in Marrone Bio Innovations, Inc. in 2020 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 25 increasing their positions, 8 reducing their positions, and 6 closing their positions.
213% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 8
83% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 6
12% more capital invested
Capital invested by funds: $62.3M → $69.8M (+$7.49M)
7% more funds holding
Funds holding: 58 → 62 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
+$1.97M |
| 2 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$1.77M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$546K |
| 4 |
State Street
Boston,
Massachusetts
|
+$368K |
| 5 |
BlackRock
New York
|
+$242K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
-$157K |
| 2 |
Goldman Sachs
New York
|
-$88.2K |
| 3 |
Primecap Management
Pasadena,
California
|
-$62.2K |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$59K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$55.3K |
MBII Hedge Fund Activity: Q4 2020 in Review
62 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q4 2020, worth a combined $69.8M — up 12% from $62.3M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new MBII positions and 6 closed out — a net gain of 5 holders — while 25 added to existing stakes and 8 trimmed.
The largest buyer was Ardsley Advisory Partners, adding an estimated $1.97M. The largest seller was Russell Investments Group, cutting an estimated $157K.
- 62 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q4 2020, up from 58 in Q3 2020.
- Funds reported $69.8M of Marrone Bio Innovations, Inc. stock for Q4 2020, up 12% quarter-over-quarter.
- 11 funds opened new Marrone Bio Innovations, Inc. positions in Q4 2020 and 6 closed out, a net change of +5 holders.
- The largest Marrone Bio Innovations, Inc. buyer in Q4 2020 was Ardsley Advisory Partners, an estimated $1.97M added.
- The largest Marrone Bio Innovations, Inc. seller in Q4 2020 was Russell Investments Group, an estimated $157K sold.
Based on aggregated 13F filings for Q4 2020.